Nanobody-161 mediated Fc-dependent CD8+ T cell activation and TNFR2+ Tregs in the tumor microenvironment were depleted by antibody-dependent cell-mediated cytotoxicity (ADCC). The gene discussed is CD8A; the disease is neoplasm.